Skip to main content
Clinical Trials/NL-OMON20381
NL-OMON20381CompletedNot Applicable

HOw feaR affects platelet aggRegability in healthy vOlunteeRs – a randomized crossover trial

one0 sites22 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
one
Enrollment
22

Study Overview

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Age between 18-30 years
  • -No prior medical history (Use of contraceptive medication with monophasic oral contraceptives or an intra-uterine device (i.e. Mirena) is permitted)

Exclusion Criteria

  • -Alcohol intake within 24 hours prior to blood sampling
  • -Abnormal platelet count (i.e. <100 or > 400 x 109)
  • -NSAID intake within 24 hours prior to blood sampling
  • -Recent use of (other) antiplatelet drugs, anticoagulants or other drugs known to alter platelet function (e.g. serotonin reuptake inhibitors)
  • -Pregnancy
  • *Platelet count will be determined after the analyses of the first blood samples. If a subject turns out to have an abnormal platelet count, he or she will be excluded from the experiment.

Investigators

Sponsor
one

Similar Trials